David A. Barda

1.2k total citations
18 papers, 708 citations indexed

About

David A. Barda is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, David A. Barda has authored 18 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in David A. Barda's work include Synthetic Organic Chemistry Methods (6 papers), DNA Repair Mechanisms (4 papers) and Asymmetric Synthesis and Catalysis (4 papers). David A. Barda is often cited by papers focused on Synthetic Organic Chemistry Methods (6 papers), DNA Repair Mechanisms (4 papers) and Asymmetric Synthesis and Catalysis (4 papers). David A. Barda collaborates with scholars based in United States and China. David A. Barda's co-authors include William Roush, Edwin Vedējs, Darlene Barnard, Constance King, Mark S. Marshall, Wayne Blosser, Richard P. Beckmann, Michael P. Johnson, Darryle D. Schoepp and Thomas C. Britton and has published in prestigious journals such as Journal of the American Chemical Society, Tetrahedron and Organic Letters.

In The Last Decade

David A. Barda

17 papers receiving 696 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Barda United States 13 426 225 188 147 46 18 708
Tina Morgan Ross United States 9 453 1.1× 140 0.6× 322 1.7× 125 0.9× 108 2.3× 14 749
Claudia Rosenbaum Germany 16 445 1.0× 276 1.2× 90 0.5× 160 1.1× 103 2.2× 26 836
Lisa D. Aimone United States 19 654 1.5× 435 1.9× 190 1.0× 211 1.4× 66 1.4× 59 1.2k
Massimo Castorina Italy 18 470 1.1× 400 1.8× 181 1.0× 69 0.5× 70 1.5× 22 935
Jennifer L. Olkowski United States 10 362 0.8× 133 0.6× 74 0.4× 102 0.7× 62 1.3× 16 589
István Kertész Hungary 15 267 0.6× 202 0.9× 136 0.7× 129 0.9× 21 0.5× 46 739
Raymond J. Patch United States 16 448 1.1× 396 1.8× 89 0.5× 157 1.1× 48 1.0× 30 902
Mohamed Iqbal Canada 16 490 1.2× 239 1.1× 170 0.9× 48 0.3× 44 1.0× 31 816
Marjan Bouma Netherlands 12 166 0.4× 76 0.3× 151 0.8× 73 0.5× 56 1.2× 20 447
Graham E. Jones United Kingdom 15 418 1.0× 221 1.0× 54 0.3× 188 1.3× 55 1.2× 21 700

Countries citing papers authored by David A. Barda

Since Specialization
Citations

This map shows the geographic impact of David A. Barda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Barda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Barda more than expected).

Fields of papers citing papers by David A. Barda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Barda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Barda. The network helps show where David A. Barda may publish in the future.

Co-authorship network of co-authors of David A. Barda

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Barda. A scholar is included among the top collaborators of David A. Barda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Barda. David A. Barda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wijeratne, Aruna, Junpeng Xiao, Kelly Furness, et al.. (2018). Chemical Proteomic Characterization of a Covalent KRASG12C Inhibitor. ACS Medicinal Chemistry Letters. 9(6). 557–562. 14 indexed citations
2.
Smith, Michèle C., Mary M. Mader, James A. Cook, et al.. (2016). Characterization of LY3023414, a Novel PI3K/mTOR Dual Inhibitor Eliciting Transient Target Modulation to Impede Tumor Growth. Molecular Cancer Therapeutics. 15(10). 2344–2356. 62 indexed citations
3.
King, Constance, Samuel McNeely, Darlene Barnard, et al.. (2015). LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms. Molecular Cancer Therapeutics. 14(9). 2004–2013. 139 indexed citations
4.
Barnard, Darlene, Teresa F. Burke, Gregory P. Donoho, et al.. (2015). LY2603618, a selective CHK1 inhibitor, enhances the anti-tumor effect of gemcitabine in xenograft tumor models. Investigational New Drugs. 34(1). 49–60. 19 indexed citations
5.
King, Constance, Darlene Barnard, David A. Barda, et al.. (2013). Characterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitor. Investigational New Drugs. 32(2). 213–226. 90 indexed citations
6.
7.
Marshall, Mhairi, et al.. (2010). 194 Characterization and preclinical development of LY2606368, a second generation Chk1 inhibitor. European Journal of Cancer Supplements. 8(7). 65–65. 1 indexed citations
8.
Marshall, Mark S., David A. Barda, Darlene Barnard, et al.. (2009). Abstract B248: Characterization and preclinical development of LCI-1, a selective and potent Chk1 inhibitor in phase 1 clinical trials. Molecular Cancer Therapeutics. 8(12_Supplement). B248–B248. 4 indexed citations
9.
Johnson, Michael P., David A. Barda, Thomas C. Britton, et al.. (2005). Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s). Psychopharmacology. 179(1). 271–283. 126 indexed citations
10.
Barda, David A., Zhaoqing Wang, Thomas C. Britton, et al.. (2004). SAR study of a subtype selective allosteric potentiator of metabotropic glutamate 2 receptor, N-(4-phenoxyphenyl)-N-(3-pyridinylmethyl)ethanesulfonamide. Bioorganic & Medicinal Chemistry Letters. 14(12). 3099–3102. 40 indexed citations
11.
12.
Roush, William & David A. Barda. (2002). Partial Stereochemical Assignment of Quartromicins A3 and D3. Organic Letters. 4(9). 1539–1542. 11 indexed citations
13.
Roush, William, David A. Barda, Chris Limberakis, & Roxanne K. Kunz. (2002). Studies on the synthesis of the quartromicins: partial stereochemical assignment of quartromicins A3 and D3 and diastereoselective synthesis of the endo- and exo-spirotetronate subunits. Tetrahedron. 58(32). 6433–6454. 19 indexed citations
14.
Roush, William, Chris Limberakis, Roxanne K. Kunz, & David A. Barda. (2002). Diastereoselective Synthesis of the endo- and exo-Spirotetronate Subunits of the Quartromicins. The First Enantioselective Diels−Alder Reaction of an Acyclic (Z)-1,3-Diene. Organic Letters. 4(9). 1543–1546. 34 indexed citations
15.
16.
Roush, William & David A. Barda. (1997). An intramolecular Diels-Alder approach to the spirotetronic acid subunits of the quartromicins. Tetrahedron Letters. 38(51). 8781–8784. 10 indexed citations
17.
Roush, William & David A. Barda. (1997). Second generation synthesis of the quartromicin spirotetronic acid subunits via a Claisen rearrangement-intramolecular aldol sequence. Tetrahedron Letters. 38(51). 8785–8788. 14 indexed citations
18.
Roush, William & David A. Barda. (1997). Highly Selective Lewis Acid Catalyzed Diels−Alder Reactions of Acyclic (Z)-1,3-Dienes. Journal of the American Chemical Society. 119(31). 7402–7403. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tina Morgan Ross Breakdown of academic impact, for papers by Claudia Rosenbaum Breakdown of academic impact, for papers by Lisa D. Aimone Breakdown of academic impact, for papers by Massimo Castorina Breakdown of academic impact, for papers by Jennifer L. Olkowski Breakdown of academic impact, for papers by István Kertész Breakdown of academic impact, for papers by Raymond J. Patch Breakdown of academic impact, for papers by Mohamed Iqbal Breakdown of academic impact, for papers by Marjan Bouma Breakdown of academic impact, for papers by Graham E. Jones
Rankless by CCL
2026